MedPath
TGA Approval

CONTRAVE 8/90 naltrexone hydrochloride 8 mg and bupropion hydrochloride 90 mg modified-release tablet blister pack (288372)

288372

CONTRAVE 8/90 naltrexone hydrochloride 8 mg and bupropion hydrochloride 90 mg modified-release tablet blister pack

iNova Pharmaceuticals (Australia) Pty Ltd

August 24, 2018

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/898cb27b66ff47da723696c830b32f72.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/e98bd2e523f867941d44505f6e7cbeb7.pdf

Active Ingredients

bupropion hydrochloride

naltrexone hydrochloride

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

CONTRAVE 8/90 naltrexone hydrochloride 8 mg and bupropion hydrochloride 90 mg modified-release tablet blister pack (288372) - TGA 批准文号 | MedPath